# DESCRIPTION

## FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

- acknowledge government support

## TECHNICAL FIELD

- define technical field of fusion proteins

## BACKGROUND

- summarize Tet1 enzyme function

## SUMMARY

- introduce fusion proteins
- describe DNA-binding domain
- describe catalytic domain
- outline methods of use

## DETAILED DESCRIPTION

- describe fusion proteins comprising DNA-binding domain and catalytic domain

### DNA-Binding Domains

- introduce DNA-binding domains
- describe TAL effector repeat arrays
- explain RVDs in TAL effectors
- describe uses of TALE proteins
- introduce zinc fingers
- describe structure and function of zinc fingers
- discuss engineering zinc finger arrays
- introduce native DBDs
- describe homing meganucleases
- describe chemical nucleases

### Catalytic Domains

- describe catalytic domains for hydroxylation of methylated cytosines

### Construction of Fusion Proteins

- describe fusion of DNA-binding domain and catalytic domain
- discuss multimerization of catalytic domains

### Methods of Use of the Fusion Proteins

- describe uses of fusion proteins for demethylation and gene regulation

### Polypeptide Expression Systems

- describe polypeptide expression systems
- introduce intermediate vectors
- motivate expression vectors
- summarize promoter selection
- describe expression cassette elements
- introduce eukaryotic expression vectors
- outline transfection and purification methods

### Use of Fusion Proteins in Gene Therapy

- introduce fusion proteins in gene therapy
- motivate gene expression regulation
- describe demethylation methods
- outline non-viral gene transfer methods
- detail lipofection methods
- describe lipid:nucleic acid complex preparation
- introduce viral vector delivery systems
- describe retroviral vectors
- detail lentiviral vectors
- outline adenoviral vectors
- describe adeno-associated virus vectors
- introduce Sendai and herpes simplex virus vectors
- describe viral vector approaches in clinical trials
- outline packaging cells and virus particles
- describe targeted gene delivery methods
- outline ex vivo and in vivo gene therapy administration

### Delivery Vehicles

- introduce polypeptide compounds
- describe cellular membranes
- motivate membrane translocation polypeptides
- summarize examples of peptide sequences
- describe toxin molecules
- motivate liposomes
- describe liposome composition
- summarize methods for preparing liposomes
- motivate targeting moieties

### Dosages

- describe dosage calculation

### Pharmaceutical Compositions and Administration

- describe pharmaceutical compositions
- motivate administration routes
- describe formulation options

## EXAMPLES

- describe examples of the invention

### Example 1

- generate TAL-Tet1 fusion proteins
- design TAL effector repeat arrays
- test demethylation of CpGs in human KLF4 gene

### Example 2

- transfect human K562 cells with TAL-Tet1-CD fusion proteins
- analyze demethylation of CpGs in KLF4 intron 1-2
- show demethylation results for different TAL-Tet1-CD fusion proteins

### Example 3

- engineer TALE-Tet1 proteins targeted to human HBB locus
- test demethylation and gene expression in human K562 cells

### Example 4

- engineer ZF-Tet1 fusion proteins and test demethylation

### Other Embodiments

- discuss scope of the invention

